Cover Image

Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria

Gram-positive bacteria do not produce lipopolysaccharide as a cell wall component. As such, the polymyxin class of antibiotics, which exert bactericidal activity against Gram-negative pathogens, are ineffective against Gram-positive bacteria. The safe-for-human-use hydroxyquinoline analog ionophore...

Full description

Saved in:
Bibliographic Details
Main Authors: David M. P. De Oliveira (Author), Bernhard Keller (Author), Andrew J. Hayes (Author), Cheryl-Lynn Y. Ong (Author), Nichaela Harbison-Price (Author), Ibrahim M. El-Deeb (Author), Gen Li (Author), Nadia Keller (Author), Lisa Bohlmann (Author), Stephan Brouwer (Author), Andrew G. Turner (Author), Amanda J. Cork (Author), Thomas R. Jones (Author), David L. Paterson (Author), Alastair G. McEwan (Author), Mark R. Davies (Author), Christopher A. McDevitt (Author), Mark von Itzstein (Author), Mark J. Walker (Author)
Format: Book
Published: MDPI AG, 2022-03-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Gram-positive bacteria do not produce lipopolysaccharide as a cell wall component. As such, the polymyxin class of antibiotics, which exert bactericidal activity against Gram-negative pathogens, are ineffective against Gram-positive bacteria. The safe-for-human-use hydroxyquinoline analog ionophore PBT2 has been previously shown to break polymyxin resistance in Gram-negative bacteria, independent of the lipopolysaccharide modification pathways that confer polymyxin resistance. Here, in combination with zinc, PBT2 was shown to break intrinsic polymyxin resistance in <i>Streptococcus pyogenes</i> (Group A <i>Streptococcus</i>; GAS), <i>Staphylococcus aureus</i> (including methicillin-resistant <i>S. aureus</i>), and vancomycin-resistant <i>Enterococcus faecium</i>. Using the globally disseminated M1T1 GAS strain 5448 as a proof of principle model, colistin in the presence of PBT2 + zinc was shown to be bactericidal in activity. Any resistance that did arise imposed a substantial fitness cost. PBT2 + zinc dysregulated GAS metal ion homeostasis, notably decreasing the cellular manganese content. Using a murine model of wound infection, PBT2 in combination with zinc and colistin proved an efficacious treatment against streptococcal skin infection. These findings provide a foundation from which to investigate the utility of PBT2 and next-generation polymyxin antibiotics for the treatment of Gram-positive bacterial infections.
Item Description:10.3390/antibiotics11040449
2079-6382

Similar Items